ChAdOx1 nCoV-19

  • IASbaba
  • July 22, 2020
  • 0
UPSC Articles
Print Friendly, PDF & Email

ChAdOx1 nCoV-19

Part of: GS Prelims and Mains III – Science – Health and Medicine; Recent developments/advancements 

In news:  

  • ChAdOx1 nCoV-19 is Oxford University’s experimental COVID-19 vaccine. 
  • According to Lancet study, the vaccine candidate produced neutralising antibodies and boosted the immune system as well.  
  • According to the Scientists, increasing T-cell response as well as antibodies could be very important in controlling COVID-19. 

For a dedicated peer group, Motivation & Quick updates, Join our official telegram channel –

Subscribe to our YouTube Channel HERE to watch Explainer Videos, Strategy Sessions, Toppers Talks & many more…

Search now.....

Sign Up To Receive Regular Updates